Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) EBT Margin: 2023-2025

Historic EBT Margin for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to -1,663.90%.

  • Camp4 Therapeutics' EBT Margin fell 2341229.00% to -1,663.90% in Q3 2025 from the same period last year, while for Sep 2025 it was -1,357.02%, marking a year-over-year change of. This contributed to the annual value of -7,943.40% for FY2024, which is 613974.00% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' EBT Margin is -1,663.90%, which was down 98.08% from -840.01% recorded in Q2 2025.
  • Over the past 5 years, Camp4 Therapeutics' EBT Margin peaked at 21,748.39% during Q3 2024, and registered a low of -3,341.71% during Q3 2023.
  • Moreover, its 3-year median value for EBT Margin was -1,458.28% (2025), whereas its average is 4,008.35%.
  • As far as peak fluctuations go, Camp4 Therapeutics' EBT Margin skyrocketed by 2,509,010bps in 2024, and later crashed by 2,341,229bps in 2025.
  • Quarterly analysis of 3 years shows Camp4 Therapeutics' EBT Margin stood at 15,650.60% in 2023, then plummeted by 1,768,726bps to -2,036.66% in 2024, then plummeted by 2,341,229bps to -1,663.90% in 2025.
  • Its last three reported values are -1,663.90% in Q3 2025, -840.01% for Q2 2025, and -1,458.28% during Q1 2025.